<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03657459</url>
  </required_header>
  <id_info>
    <org_study_id>18-442</org_study_id>
    <nct_id>NCT03657459</nct_id>
  </id_info>
  <brief_title>Danger Signs in Heart Failure- Effects of Video Education</brief_title>
  <official_title>Danger Signs of Worsening Heart Failure and Self-Management of Danger Signs: The Effects of Video Education</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wellflix, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lack of recognition of HF danger signs and lack of understanding of how to control and
      minimize danger signs could lead to their escalation and prompt all-cause and HF-related
      health care resource utilization (HCRU). Investigators hypothesize that patients must
      understand HF danger signs to have self-confidence in recognizing them and in taking steps to
      minimize or eliminate their occurrence post hospital discharge. Investigators will determine
      if video education in HF danger signs recognition and control prior to discharge (and
      post-discharge) reduces all-cause and HF-related HCRU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most frequently cited danger signs of heart failure (HF) are new onset or worsening of
      fatigue, dyspnea and edema. In previous research, patients did not recognize worsening HF,
      due to 3 primary reasons: (1) danger signs were non-specific and misinterpreted as stress, an
      external force or another comorbidity, (2) danger signs were unrecognized due to the subtle
      nature of worsening status, or (3) when patients eliminated or minimized activities that
      prompted danger signs, they interpreted the results as improvement in status. Lack of
      recognition of HF danger signs and lack of understanding of how to control and minimize
      danger signs could lead to their escalation and prompt all-cause and HF-related health care
      resource utilization (HCRU). Investigators hypothesize that patients must understand HF
      danger signs to have self-confidence in recognizing them and in taking steps to minimize or
      eliminate their occurrence post hospital discharge. The purposes of this trial are to
      determine if video education in HF danger signs recognition and control prior to discharge
      (and post-discharge) reduces all-cause and HF-related health care resource utilization. The
      intervention will be administered during hospitalization, and patients and family members
      will receive a link to a website and a DVD to review videos as often as desired
      post-discharge. The primary end-point is 30-day HF-related hospitalization. 732 patients (658
      + 10% attrition) with decompensated HF will be enrolled from multiple hospitals.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 26, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, controlled prospective trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
    <masking_description>Documentation of enrollment will not include group assignment Investigator will be blinded from group assignment via a separate excel file with that detail</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>First occurrence of HF-related healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 30 days</time_frame>
    <description>First occurrence of post-discharge HF-related HCRU: hospitalization, emergency department [ED) visits, death or cardiac transplantation/ ventricular assist device [VAD] implant (composite)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First occurrence of HF-related hospitalization</measure>
    <time_frame>up to 30 days</time_frame>
    <description>First occurrence of post-discharge HF-related hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of HF-related ED visit</measure>
    <time_frame>up to 30 days</time_frame>
    <description>First occurrence of post-discharge HF-related ED visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of post-discharge HF-related death or cardiac transplantation /ventricular assist device placement</measure>
    <time_frame>up to 30 days</time_frame>
    <description>First occurrence of post-discharge HF-related death or cardiac transplant/VAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of HF-related hospitalization</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of HF-related ED visit</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related ED visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of HF-related death or cardiac transplant/VAD</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related death or cardiac transplant/VAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of all-cause healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 30 days</time_frame>
    <description>First occurrence of post-discharge all-cause HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of all-cause healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge all-cause HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of all-cause hospitalization</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of all-cause ED visit</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related ED visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First occurrence of all-cause death or cardiac transplant/VAD</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related death or cardiac transplant/VAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total all-cause healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 180 days</time_frame>
    <description>Total post-discharge all-cause HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total HF-related healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 180 days</time_frame>
    <description>Total post-discharge HF-related HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of HF-related healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of HF-related hospitalization</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of HF-related ED visit</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related ED visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of HF-related death or cardiac transplantation/VAD</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related death or cardiac transplantation/VAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of all-cause healthcare resource utilization (HCRU)</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge all-cause HCRU (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of all-cause hospitalization</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of all-cause ED visit</measure>
    <time_frame>180 days</time_frame>
    <description>First occurrence of post-discharge HF-related ED visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of all-cause death or cardiac transplantation/VAD</measure>
    <time_frame>up to 180 days</time_frame>
    <description>First occurrence of post-discharge HF-related death or cardiac transplantation/VAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Functional status from baseline</measure>
    <time_frame>up to 180 ays</time_frame>
    <description>Change in Duke Activity Status Index (DASI) score from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dyspnea from baseline</measure>
    <time_frame>up to 180 ays</time_frame>
    <description>Change in PROMISÂ® Dyspnea Functional Limitations - Short Form 10a from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fatigue from baseline</measure>
    <time_frame>up to 180 ays</time_frame>
    <description>Change in a 10-item Fatigue Assessment Scale from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-efficacy for managing symptoms, from baseline</measure>
    <time_frame>up to 180 ays</time_frame>
    <description>Change in PROMIS Self-Efficacy for Managing Symptoms Short form 8a for managing symptoms, from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Among intervention patients, HCRU based on all video views</measure>
    <time_frame>30 days</time_frame>
    <description>Among intervention patients, differences in HCRU based on number of video views</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Among intervention patients, HCRU based on video views with family in hospital</measure>
    <time_frame>30 days</time_frame>
    <description>Among intervention patients, differences in HCRU based on video viewing with family (Y/N) in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Among intervention patients, HCRU based on video views with family post hospital discharge</measure>
    <time_frame>30 days</time_frame>
    <description>Among intervention patients, differences in HCRU based on video viewing with family (Y/N) post hospital discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">732</enrollment>
  <condition>Heart Failure; With Decompensation</condition>
  <arm_group>
    <arm_group_label>usual care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care consists of patient's receiving a Heart Failure Handbook before hospital discharge + verbal education delivered by multiple care providers (including a group education class at 1 site). The handbook is consistent; however, verbal education may vary between care providers based on their knowledge and time available, and perceived patient needs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>video education group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive usual care, plus will watch 2 short Wellflix, Inc. Danger Signs of Heart Failure videos (via iPAD) on dyspnea, fatigue + a Danger Sign &quot;edema&quot; video, when applicable. Each video describes how to recognize if the sign/symptom is new or worsening and how to self-manage at home (via diet, fluid management and activity instructions)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Danger Signs of Heart Failure Videos</intervention_name>
    <description>Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities)</description>
    <arm_group_label>video education group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Not referred for cardiac transplantation or ventricular assist device placement during
             the index hospitalization,

          -  Cognitively intact and able to view videos (adequate eyesight and hearing) with
             correction, if needed,

          -  Discharge to home, assisted living facility or to a family member's home and can
             control dietary sodium and fluids as needed,

          -  Willing to participate; which may require up to three (3) follow-up telephone calls
             post-discharge.

        Exclusion Criteria:

          -  Chart documented psychiatric or cognitive conditions that limit ability to understand
             video content or adhere to self-care recommendations (Alzheimer's condition, dementia,
             schizophrenia, other neurological history that impairs memory or concentration),

          -  Plans to discharge to skilled nursing facility or hospice care,

          -  Receiving home hospice or palliative care; or has a medical condition reflecting less
             than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory
             New York Heart Association functional class IV HF),

          -  Hospitalized but at admission, in New York Heart Association functional class I or II
             HF

          -  Post-cardiac transplantation or ventricular assist device placement,

          -  Currently enrolled in another experimental HF research study,

          -  Chronic renal failure and receiving chronic hemodialysis therapy for an estimated
             glomerular filtration rate &lt; 15 mL/minute/1.73 m2,

          -  A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy,
             congenital heart disease or Takotsubo cardiomyopathy).
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Please answer each question as it applies to you.
Sex: 0.______ Male 1.______ Female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NANCY M. ALBERT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>NANCY M. ALBERT, PhD</last_name>
    <phone>2164447028</phone>
    <phone_ext>2164447028</phone_ext>
    <email>albertn@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Center Navicent Health</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Fairview Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NANCY M ALBERT, PhD</last_name>
      <phone>216-444-7028</phone>
      <phone_ext>2164447028</phone_ext>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic main campus</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NANCY M ALBERT, PhD</last_name>
      <phone>216-444-7028</phone>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Marymount Hospital</name>
      <address>
        <city>Garfield Heights</city>
        <state>Ohio</state>
        <zip>44125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy M Albert, PhD</last_name>
      <phone>216-444-7028</phone>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Hillcrest Hospital</name>
      <address>
        <city>Mayfield Heights</city>
        <state>Ohio</state>
        <zip>44124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NANCY M ALBERT</last_name>
      <phone>216-444-7028</phone>
      <phone_ext>2164447028</phone_ext>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Medina Hospital</name>
      <address>
        <city>Medina</city>
        <state>Ohio</state>
        <zip>44256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy M Albert, PhD</last_name>
      <phone>216-444-7028</phone>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic South Pointe Hospital</name>
      <address>
        <city>Warrensville Heights</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy M Albert, PhD</last_name>
      <phone>216-444-7028</phone>
      <email>albertn@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>WellSpan Health</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>15198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Maria Gray-Leyko, MS, RN, AGCNS-BC</last_name>
      <email>agrayleyko@wellspan.org</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Bucho,, DNP, RNC-MNN</last_name>
      <phone>717-851-2434</phone>
      <email>bbuchko@wellspan.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 30, 2018</study_first_submitted>
  <study_first_submitted_qc>September 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2018</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Nancy M. Albert, Ph.D.</investigator_full_name>
    <investigator_title>Assocaite Chief Nursing Officer-Resaerch and Senior Nurse Scientist</investigator_title>
  </responsible_party>
  <keyword>video education</keyword>
  <keyword>self care management</keyword>
  <keyword>symptom recognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plans to share individual data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

